Literature DB >> 2621573

Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove-binding intercalating drugs.

C Bailly1, N Pommery, R Houssin, J P Henichart.   

Abstract

A group of pseudopeptides, molecular combination of the natural antitumor agents distamycin or netropsin and the anilinoacridine chromophore (which is related to the synthetic antileukemic drug amsacrine) has been synthesized. Their DNA binding properties were determined and discussed in terms of their structural differences and in relation to their observed base-dependent binding. Binding data are consistent with a model in which the acridine nucleus occupies an intercalation site and the netropsin or distamycin residue resides in the DNA minor groove. Cytostatic and cytotoxic activities against a murine cell line are reported, as well as significant differences in the inhibition of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621573     DOI: 10.1002/jps.2600781106

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Binding site size limit of the 2:1 pyrrole-imidazole polyamide-DNA motif.

Authors:  J J Kelly; E E Baird; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer agents.

Authors:  Rui Zhang; Xing Wu; Lynn J Guziec; Frank S Guziec; Gaik-Lean Chee; Jack C Yalowich; Brian B Hasinoff
Journal:  Bioorg Med Chem       Date:  2010-04-18       Impact factor: 3.641

3.  Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311.

Authors:  A M Burger; T C Jenkins; J A Double; M C Bibby
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.